Cost Effectiveness of Roxithromycin Versus Cefaclor in Australia
- 1 January 1995
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 7 (1) , 93-94
- https://doi.org/10.2165/00019053-199507010-00009
Abstract
No abstract availableKeywords
This publication has 1 reference indexed in Scilit:
- Roxithromycin versus Cefaclor in Lower Respiratory Tract InfectionPharmacoEconomics, 1993